Jack Kochanowicz sidelined for Tommy John surgery

Jack Kochanowicz's promising career hit a major roadblock Tuesday.

RG
Rachel Goldberg

June 10, 2026 · 2 min read

Baseball pitcher Jack Kochanowicz looking somber as he walks off the mound, symbolizing the impact of his Tommy John surgery diagnosis.

Jack Kochanowicz's promising career hit a major roadblock Tuesday. An MRI revealed a torn UCL, sidelining him for the entire 2026 season for Tommy John surgery, according to RotoWire, cbssports, and Sports Illustrated.

Tommy John surgery boasts a high success rate for pitchers returning to the mound, but their careers post-surgery are often shorter and less predictable. This creates a paradox: medical advancement ensures a return, but not sustained impact.

Therefore, while Kochanowicz has a good chance of returning, his future impact and longevity in the MLB are now considerably more uncertain. This redefines 'success' for a pitcher undergoing this operation, suggesting a potentially truncated career rather than a full recovery.

The High Probability of Return and Recovery Timeline

Data from pubmed.ncbi.nlm.nih.gov/23075528/ indicates 148 out of 179 pitchers (83%) returned to MLB pitching after UCL reconstruction, averaging 20.5 ± 9.72 months for recovery. While Kochanowicz faces a lengthy recovery of nearly two years, the high return rate does not guarantee sustained high-level performance or career longevity. The initial success masks subsequent challenges.

Long-Term Career Outlook and Risks

Post-UCL reconstruction, MLB pitchers averaged a career length of just 3.9 ± 2.84 years, according to pubmed.ncbi.nlm.nih.gov/23075528/. This challenges the idea that returning to play means a sustained career. A low 3.9% revision rate for UCL reconstruction suggests career curtailment stems from factors beyond re-tearing the ligament, such as diminished performance or increased injury risk elsewhere. Therefore, Kochanowicz's return, while probable, will likely be a race against time, as the 83% return rate masks a significant professional cost. Teams investing in post-TJ pitchers like Kochanowicz are betting on a short-term, high-impact window, demanding immediate performance contribution beyond simply rejoining the roster.

Historical Precedent for Post-Surgery Careers

While 56 pitchers who underwent UCL reconstruction were still active in MLB at the start of the 2013 season (pubmed.ncbi.nlm.nih.gov/23075528/), this offers limited hope for sustained careers. The 83% success rate for Tommy John surgery misrepresents true career longevity. Kochanowicz's 20.5-month recovery aligns with the average, but this extended absence during critical developmental years could permanently hinder his pre-injury potential. The competitive landscape does not pause for recovery, demanding immediate impact upon his return.

Filling the Void and Kochanowicz's Future

With Kochanowicz sidelined, the team must rely on other prospects, such as Caden Dana, who holds a 1.117 WHIP in the Pacific Coast League, according to Sports Illustrated. This immediate need pressures developing talent. Kochanowicz faces an arduous journey; his extended absence during critical developmental years could permanently hinder his pre-injury potential. Therefore, Kochanowicz's future success likely hinges on his ability to not only recover physically but also to accelerate his development for immediate impact upon his projected 2028 return.